BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 19408510)

  • 1. [Prognostic impact of different tumor invasion patterns in the surgical treatment of T3 glottic laryngeal cancer].
    Ling Z; Hu G; Wang Z; Ma W; Wang X; Zhu J; Zeng Q
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2023 Dec; 37(12):998-1004. PubMed ID: 38114321
    [No Abstract]   [Full Text] [Related]  

  • 2. Extended partial laryngectomy with functional preservation using the rotational crico-thyrotracheopexy.
    Rovó L; Szakács L; Castellanos PF; Tóbiás Z; Pfiszterer P; Ambrus A; Csanády M; Bach Á
    Laryngoscope Investig Otolaryngol; 2023 Oct; 8(5):1328-1336. PubMed ID: 37899879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial laryngectomies: when the problem is the pexy.
    Ruberto M; Alicandri-Ciufelli M; Grammatica A; Marchioni D; Bergamini G; Presutti L
    Acta Otorhinolaryngol Ital; 2014 Aug; 34(4):247-52. PubMed ID: 25210218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Function preservation using transoral laser surgery for T2-T3 glottic cancer: oncologic, vocal, and swallowing outcomes.
    Peretti G; Piazza C; Del Bon F; Mora R; Grazioli P; Barbieri D; Mangili S; Nicolai P
    Eur Arch Otorhinolaryngol; 2013 Aug; 270(8):2275-81. PubMed ID: 23568037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Supracricoid partial laryngectomy with cricohyoidoepiglottopexy and cricohyoidopexy for glottic and supraglottic carcinomas.
    Bron L; Brossard E; Monnier P; Pasche P
    Laryngoscope; 2000 Apr; 110(4):627-34. PubMed ID: 10764009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cricohyoidopexy (CHP) and Cricohyoidoepiglottopexy (CHEP). Indication, complications, functional und oncological results].
    Schröder U; Jungehülsing M; Klussmann JP; Eckel HE
    HNO; 2003 Jan; 51(1):38-45. PubMed ID: 12557096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supracricoid partial laryngectomy with crico-hyoido-epiglottopexy for glottic carcinoma with anterior commissure involvement.
    Atallah I; Berta E; Coffre A; Villa J; Reyt E; Righini CA
    Acta Otorhinolaryngol Ital; 2017 Jun; 37(3):188-194. PubMed ID: 28516961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supracricoid laryngectomy with cricohyoidoepiglotto-pexy or cricohyoido-pexy: experience on 32 patients.
    Nakayama M; Okamoto M; Miyamoto S; Takeda M; Yokobori S; Masaki T; Seino Y
    Auris Nasus Larynx; 2008 Mar; 35(1):77-82. PubMed ID: 17869042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Supra-cricoid partial laryngectomy extended to the anterior arch of the cricoid with tracheo-crico-hyoido-epiglottopexy. Oncologic and functional results].
    Laccourreye O; Brasnu D; Jouffre V; Couloigner V; Naudo P; Laccourreye H
    Ann Otolaryngol Chir Cervicofac; 1996; 113(1):15-9. PubMed ID: 8763770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic management of glottic tumours: about a series of 41 cases of subtotal laryngectomy with cricohyoidoepiglottopexy (CHEP)].
    Tea B; Morel N; Chahine K; Sulaj H; Reyt E; Righini CA
    Rev Laryngol Otol Rhinol (Bord); 2008; 129(4-5):277-83. PubMed ID: 19408510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Supracricoid laryngectomy with cricohyoidopexy for recurrence of early-stage glottic carcinoma after irradiation. Long-term oncological and functional results.
    Marchese-Ragona R; Marioni G; Chiarello G; Staffieri A; Pastore A
    Acta Otolaryngol; 2005 Jan; 125(1):91-5. PubMed ID: 15799582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of advanced-stage laryngeal cancer.
    Levine PA; Brasnu DF; Ruparelia A; Laccourreye O
    Otolaryngol Clin North Am; 1997 Feb; 30(1):101-12. PubMed ID: 8995139
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.